Michael Manns, MD

Michael Manns, MD, director, Department of Gastroenterology, Hepatology and Endocrinology,&nbsp;Medical School of Hannover in Germany, explains the possible link between hepatitis C and hepatocellular carcinoma.

Manns says that patients who contracted hepatitis C or cirrhosis have showcased a greater risk of developing hepatocellular carcinoma (HCC), though drawing a direct link between the virus and HCC is difficult due to treatment of the virus&nbsp;depleting the potential control group. He&nbsp;concludes by pointing out that if a link is to be drawn between Hepatitis C and HCC, further testing must be done.

Videos

Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.

Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma 

Manns explains the inefficiency of prior treatments for Hepatitis C and how current treatments could produce less adverse effects and potentially prevent cancer. In the past, treatments lasted as long as one year, but new testing has shown that it can be reduced to as little as 12 weeks. Manns also discusses the information that is needed, in order to continue with testing in the future.

Michael Manns, MD, chairman for the Department of Gastroenterology, Hepatology, and Endocrinology, Center of Internal Medicine, Hanover Medical School, Hanover, Germany, Vice President, United European Gastroenterology (UEG), discusses testing and treatment for Hepatitis C in patients with, as well as without, Hepatocellular carcinoma (HCC) liver cancer.

Michael Manns, MD | Authors

Articles

Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma

Testing and Treatment for Hepatitis C in Patients With HCC